2026-10-01
critical
Primary completion pushed: 2026-09 → 2027-07
Completion pushed: 2026-10 → 2027-08
2026-05-26
notable
Study Status, Contacts/Locations v11
Primary completion pushed: 2026-06 → 2026-09
Completion pushed: 2026-08 → 2026-10
Study sitescontacts updated at 3 of 3 sites
2026-02-04
minor
Study Status, Outcome Measures, Contacts/Locations v10
Primary completion date2025-12→2026-06
Completion date2026-01→2026-08
2025-07-23
minor
Study Status v9
Primary completion date2025-06→2025-12
Completion date2025-07→2026-01
2025-04-23
minor
Study Status, Contacts/Locations v8
Study sitescontacts updated at 3 of 3 sites
Show 7 earlier versions
2024-08-15
minor
Study Status, Contacts/Locations v7
Primary completion date2024-12-31→2025-06
Completion date2025-01-31→2025-07
Study sites2→3
2023-07-24
minor
Study Status v6
Primary completion date2023-12-31→2024-12-31
Completion date2024-01-31→2025-01-31
2023-02-24
minor
Study Status, Contacts/Locations v5
Start date2020-02-12→2021-12-06
Study sitescontacts updated at 2 of 2 sites
2022-06-15
minor
Study Status, Eligibility v4
Eligibility criteria+28 characters
[...] (NCI-CTC-AE, Version 5.0) Scale ≥ 60 days post-chemotherapy
HaveIf solid tumor cancer, must have non-metastatic cancer
Agree to return to clinic for require [...]
2022-04-12
minor
Study Status v3
Primary completion date2022-08-21→2023-12-31
Completion date2023-08-21→2024-01-31
2021-02-26
minor
Study Status v2
Primary completion date2021-01-30→2022-08-21
Completion date2021-01-30→2023-08-21
2020-02-20
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2020-01-30→confirmed 2020-02-12
Study sitesdetails revised at 2 of 2 sites
2019-12-19
minor
Original filing